MiNK Therapeutics shared by ODC Life Sciences, on LinkedIn:
“MiNK Therapeutics President and CEO Jennifer S. Buell join ‘Clinical Development in LATAM: Brazil Unlocked’ on September 24.
Drawing on more than 25 years of experience advancing new therapies from discovery through clinical development, Jennifer will share her perspective on building programs that can reach patients across geographies.
Join the conversation in Cambridge or online. Registration details are included below.”
Quoting ODC Life Sciences:
“Clinical Development in LATAM: Brazil Unlocked
Speaker Confirmed: Jennifer S. Buell
Jennifer Buell is the CEO of MiNK Therapeutics, and will be joining us at Clinical Development in LATAM: Brazil Unlocked, to share her experience on building companies that bring new therapies to patients.
Jennifer has spent more than 25 years moving therapies from discovery to patients, now leading a company pioneering iNKT cell therapies. She brings a builder’s view of what it takes to run trials that reach further.
Join our event with MassBio on September 24 in Cambridge, MA, and online.”
Registration is open, seats are limited.
